Displaying drugs 1876 - 1900 of 2785 in total
Name | Weight | Structure | Description | Categories |
---|---|---|---|---|
Enzalutamide | 464.436 C21H16F4N4O2S | A second-generation androgen receptor inhibitor used to treat castration-resistant prostate cancer and metastatic castration-sensitive prostate cancer. | Antiandrogens | |
Enzacamene | 254.373 C18H22O | An ingredient used in sunscreen to block UVB radiation. | Sunscreen Agents | |
Entrectinib | 560.65 C31H34F2N6O2 | Entrectinib is indicated for the treatment of metastatic ROS1-positive non-small cell lung cancer in adults. Entrectinib is also indicated in adults and children over 12 years old for the treatment... | Protein Kinase Inhibitors | |
Entecavir | 277.2792 C12H15N5O3 | A nucleoside analogue used in the treatment of chronic hepatitis B for patients with active viral replication, histological evidence of active disease, or persistent elevations in liver transaminases. | Nucleoside and Nucleotide Reverse Transcriptase Inhibitors | |
Entacapone | 305.286 C14H15N3O5 | A selective reversible catechol-O-methyltransferase inhibitor for the treatment of Parkinson's disease. | Anti-Parkinson Drugs | |
Ensulizole | 274.29 C13H10N2O3S | An ingredient used in sunscreens to absorb UVB radiation. | Acids / Acids, Noncarboxylic / Heterocyclic Compounds, Fused-Ring / Sulfur Acids / Sulfur Compounds / Sunscreen Agents | |
Enprofylline | 194.1906 C8H10N4O2 | Used in the management of symptoms of asthma. Also used in the treatment of peripheral vascular diseases and in the management of cerebrovascular insufficiency, sickle cell disease, and diabetic neuropathy. | Adenosine A2 Receptor Antagonists / Anti-Asthmatic Agents / Bronchodilator Agents | |
Enoximone | 248.301 C12H12N2O2S | A selective phosphodiesterase inhibitor indicated in the short term treatment of congestive heart failure. | Phosphodiesterase Inhibitors | |
Enoxaparin | Not Available | A low molecular weight heparin used for the prophylaxis of deep vein thrombosis and ischemic complications of unstable angina and non-Q-wave myocardial infarction. | Heparin Group | |
Enoxacin | 320.3189 C15H17FN4O3 | For the treatment of adults (≥18 years of age) with the following infections caused by susceptible strains of the designated microorganisms: (1) uncomplicated urethral or cervical gonorrhea due to Neisseria... | Anti-Bacterial Agents | |
Enmetazobactam | 314.32 C11H14N4O5S | A beta-lactamase inhibitor used to treat complicated urinary tract infections in combination with cefepime. | beta-Lactamase Inhibitors | |
Enflurane | 184.492 C3H2ClF5O | A halogenated inhalational anesthetic agent used for the induction and maintenance of anesthesia and for analgesia during labor and delivery. | Anesthetics, General / Anesthetics, Inhalation / Methyl Ethers | |
Encorafenib | 540.01 C22H27ClFN7O4S | A kinase inhibitor used to treat unresectable or metastatic melanoma with specific mutations. | B-Raf serine-threonine kinase (BRAF) inhibitors / Protein Kinase Inhibitors | |
Encainide | 352.4699 C22H28N2O2 | A voltage-gated sodium channel blocker used for management of atrial or ventricular fibrillation, atrial flutter, and ventricular tachycardia, that is no longer used due to proarrhythmic adverse effects. | Antiarrhythmic agents / Antiarrhythmics, Class Ic | |
Enasidenib | 473.383 C19H17F6N7O | An isocitrate dehydrogenase-2 inhibitor used to treat relapsed or refractory acute myeloid leukemia with an isocitrate dehydrogenase-2 mutation. | Isocitrate Dehydrogenase 2 Inhibitor | |
Enalaprilat | 348.3936 C18H24N2O5 | An antihypertensive agent used for the management of hypertension when oral therapy is not practical. | Angiotensin-Converting Enzyme Inhibitors / Antihypertensive Agents / Antihypertensive Agents Indicated for Hypertension / Drugs causing inadvertant photosensitivity | |
Enalapril | 376.4467 C20H28N2O5 | A prodrug of an ACE inhibitor used to treat hypertension and congestive heart failure. | ACE Inhibitors and Calcium Channel Blockers / ACE Inhibitors and Diuretics | |
Emtricitabine | 247.247 C8H10FN3O3S | A nucleoside reverse transcriptase inhibitor used for the treatment and prophylaxis of HIV. | Anti-HIV Agents / Antiviral Agents / Deoxycytidine / Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor / Nucleoside and Nucleotide Reverse Transcriptase Inhibitors / Reverse Transcriptase Inhibitors | |
Empagliflozin | 450.91 C23H27ClO7 | An SGLT2 inhibitor used to manage type 2 diabetes mellitus. | Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors / Sodium-Glucose Transporter 2 Inhibitors | |
Emedastine | 302.4145 C17H26N4O | A selective H1-receptor antagonist used topically to manage symptoms of allergic conjunctivitis. | Anti-Allergic Agents / Histamine H1 Antagonists / Histamine H1 Inhibitors | |
Elvitegravir | 447.884 C23H23ClFNO5 | An antiretroviral agent used in combination with other antiretrovirals for the treatment of HIV-1 infection in antiretroviral treatment-experienced adults. | Anti-HIV Agents / Anti-Retroviral Agents / HIV Integrase / Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor / Integrase Inhibitors | |
Eluxadoline | 569.662 C32H35N5O5 | A mixed mu-opioid receptor agonist used to treat irritable bowel syndrome with diarrhea. | Antipropulsives / Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome | |
Eltrombopag | 442.4666 C25H22N4O4 | A thrombopoietin receptor agonist used to treat thrombocytopenia or aplastic anemia associated with various etiologies. | Thrombopoietin Receptor Agonist | |
Eliglustat | 404.551 C23H36N2O4 | A glucosylceramide synthase used to treat type 1 Gaucher disease in patients who are CYP2D6 extensive, intermediate, or poor metabolizers. | Various Alimentary Tract and Metabolism Products | |
Elexacaftor | 597.66 C26H34F3N7O4S | A small molecule CFTR corrector used in combination with tezacaftor and ivacaftor for the treatment of cystic fibrosis patients with one F508del-CFTR mutation. | Cystic Fibrosis Transmembrane Conductance Regulator Correctors / Cytochrome P-450 CYP1A2 Inhibitors / Cytochrome P-450 CYP1A2 Inhibitors (strength unknown) / Cytochrome P-450 CYP2B6 Inhibitors / Cytochrome P-450 CYP2B6 Inhibitors (strength unknown) / Cytochrome P-450 CYP2C19 Inhibitors / Cytochrome P-450 CYP2C19 inhibitors (strength unknown) / Cytochrome P-450 CYP2C8 Inhibitors / Cytochrome P-450 CYP2C8 Inhibitors (strength unknown) / Cytochrome P-450 CYP2C9 Inhibitors / Cytochrome P-450 CYP2C9 Inhibitors (strength unknown) / Cytochrome P-450 CYP2D6 Inhibitors / Cytochrome P-450 CYP2D6 Inhibitors (strength unknown) / Cytochrome P-450 CYP3A Inhibitors / Cytochrome P-450 CYP3A Substrates / Cytochrome P-450 CYP3A4 Inhibitors / Cytochrome P-450 CYP3A4 Inhibitors (strength unknown) / Cytochrome P-450 CYP3A4 Substrates / Cytochrome P-450 CYP3A4 Substrates (strength unknown) / Cytochrome P-450 CYP3A5 Substrates / Cytochrome P-450 Enzyme Inhibitors / Cytochrome P-450 Substrates / Membrane Transport Modulators / OATP1B1/SLCO1B1 Inhibitors / OATP1B3 inhibitors / P-glycoprotein inhibitors / P-glycoprotein substrates |
Displaying drugs 1876 - 1900 of 2785 in total